Your browser doesn't support javascript.
loading
Alemtuzumab depletion failure can occur in multiple sclerosis.
Dubuisson, Nicolas; Baker, David; Kang, Angray S; Pryce, Gareth; Marta, Monica; Visser, Leo H; Hofmann, Werner E; Gnanapavan, Sharmilee; Giovannoni, Gavin; Schmierer, Klaus.
Afiliação
  • Dubuisson N; BartsMS, Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK.
  • Baker D; BartsMS, Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK.
  • Kang AS; BartsMS, Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK.
  • Pryce G; BartsMS, Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK.
  • Marta M; BartsMS, Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK.
  • Visser LH; Emergency Care & Acute Medicine Clinical Academic Group Neuroscience, The Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Hofmann WE; Neurology, Elisabeth-TweeSteden Ziekenhuis, Tilburg, The Netherlands.
  • Gnanapavan S; Gemeinschaftspraxis Drs Hofmann & Olschewski, Aschaffenburg, Germany.
  • Giovannoni G; BartsMS, Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK.
  • Schmierer K; Emergency Care & Acute Medicine Clinical Academic Group Neuroscience, The Royal London Hospital, Barts Health NHS Trust, London, UK.
Immunology ; 154(2): 253-260, 2018 06.
Article em En | MEDLINE | ID: mdl-29247512
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Depleção Linfocítica / Alemtuzumab / Esclerose Múltipla Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Immunology Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Depleção Linfocítica / Alemtuzumab / Esclerose Múltipla Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Immunology Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido